Hepatitis B Trial, Recruiting NCT07563309 Sponsor: bioLytical Laboratories Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT07563309
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are willing and able to sign and date a consent form agreeing to take part
  • You are able to complete the required tests on the day you are scheduled for testing
  • You can speak, read, and write English, or a translator can be available for you
  • You are getting tested for HIV, Syphilis, and/or Hepatitis B — whether because you may be at risk, you have symptoms, or it is a routine check-up
  • You do not know your HIV status, or you are HIV positive but have been on HIV treatment (ART) for less than 12 months
  • You are willing to give a small finger-prick blood sample and a blood sample taken from a vein (about 16 ml in total)
  • You are willing to take part in the testing site's standard counselling and testing program and receive your results through them
  • Note: If you are pregnant and have been re-infected with one of the conditions being tested, you may still be eligible to participate

Who may not be able to join:

  • You have a bleeding disorder
  • You are currently receiving treatment for Syphilis
  • You have previously received an experimental HIV vaccine
  • You received a Hepatitis B vaccine within the last 7 days
  • You are HIV positive and have been on HIV treatment (ART) for 12 months or longer
  • You have any other condition that the trial doctor feels would make it unsafe or unsuitable for you to participate, or that might affect the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 16042046784

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
bioLytical Laboratories
Registry
ClinicalTrials.gov
Start date
18 December 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

Performance Evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov